Evolutionary Scale

New York, NY, United States AI / Life Sciences Acquired

Evolutionary Scale (stylized EvolutionaryScale) is a frontier AI research lab and Public Benefit Corporation building large-scale generative models for biology. Founded in 2023 by former members of Meta FAIR's protein team that developed ESM1, the company launched publicly in June 2024 with ESM3, a 98-billion-parameter multimodal generative model trained on 2.78 billion protein sequences that jointly reasons over protein sequence, structure, and function. The technology is used by researchers and pharma partners for protein engineering, drug discovery, and synthetic biology, distributed via AWS and NVIDIA BioNeMo. In November 2025, the EvolutionaryScale team and technology joined Chan Zuckerberg Biohub in a strategic transaction with the Chan Zuckerberg Initiative; co-founder Alex Rives was named Head of Science for CZI.

Acquired

Evolutionary Scale has been acquired

Acquired by Chan Zuckerberg Biohub / Chan Zuckerberg Initiative November 2025 Undisclosed

This company is no longer available on our private secondary market.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2023

Employees

41–60

Total Funding

$142M

1 rounds

Funding

Total raised $142M across 1 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-25-2026

Latest Round

Type

Seed

Date

June 25, 2024

Amount

$142M

Valuation

Lead Investors

Nat FriedmanDaniel GrossLux Capital

Leadership

  • Alexander Rives

    Co-Founder, CEO & Chief Scientist

    LinkedIn
  • Tom Sercu

    Co-Founder & VP of Engineering

  • Salvatore Candido

    Co-Founder & CTO

  • Roshan Rao

    Co-Founder

  • Thomas Hayes

    Co-Founder

  • Halil Akin

    Co-Founder

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • Isomorphic Labs

    Alphabet spinout commercializing AlphaFold-derived AI models for drug discovery and protein design.

  • Cradle Bio

    Generative-AI protein engineering platform serving biotech and chemical R&D customers.

  • Profluent Bio

    AI lab building protein language models for therapeutic and gene-editing protein design.

  • Generate Biomedicines

    Flagship Pioneering company applying generative biology to design novel therapeutic proteins.

  • Inceptive

    AI biology lab founded by ex-Google Brain researchers designing RNA and other biomolecules with deep learning.

  • Chai Discovery

    AI lab building foundation models for molecular structure prediction and drug design.

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.